Collection of Blood, Bone Marrow, Skin, Saliva, and Stool Samples From Healthy Volunteers Used for Comparative Analysis of Myeloid Malignancies
Part of paid clinical trials in Bethesda, Maryland.
- Sponsor
- National Cancer Institute (NCI)
- Study ID
- NCT05588154
- Status
- Recruiting
Conditions
- Myelodysplastic Syndromes
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 120 Years
- Healthy Volunteers
- Accepted
Study Details
Background: Myelodysplastic syndromes (MDS) are disorders of blood stem cells that can develop into blood cancers. Treatment options are limited. To find better treatments, researchers need to better understand how MDS develops. To do that, they must be able to compare biospecimens from people with the disease to those of healthy people. Objective: This study will create a database of biospecimens collected from healthy volunteers. Eligibility: Healthy people aged 18 and older. Design: Participants will be screened. They will have a physical exam with blood and urine tests. Up to 5 types of samples will be collected on 1 or more days within 1 month of screening: Blood: Blood will be drawn by inserting a needle into a vein. Saliva: Participants will scrape the insides of their cheeks with a brush. Stool: Participants will be given a container to collect stool at home. They will use a prepaid envelope to mail in the sample. Bone marrow: A sample of the soft tissue inside the bones will be drawn out. The area to be biopsied, usually the lower back, will be numbed. A needle will be inserted through a small cut to remove the sample. Participants' pain will be monitored; additional numbing medicine may be used. Skin: A piece of skin about 1/6 of an inch across will be cut away. Stitches may be used to close the wound. Participants will return to the clinic to have the stitches removed. Participants do not have to provide all of the samples listed. They will give each sample only once.
Key Dates
- Start date
- Jan 11, 2023
- Status verified
- May 2026
- Primary completion
- Dec 1, 2052
- Completion
- Dec 1, 2052
Study Design
- Enrollment
- 1,000 participants (estimated)
Arms
- Arm: Cohort 1Healthy volunteers who will donate blood, and/or bone marrow and may donate other samples
- Arm: Cohort 2Healthy volunteers who will donate stool samples only
Primary Outcome Measure
create a database of analyzed biospecimens [ Time Frame: ongoing ]
Central Contacts
- Ashley E Carpenter(240) 550-0492
- Kathy L McGraw, Ph.D.(240) 760-7134
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| National Institutes of Health Clinical Center | Bethesda | Maryland | 20892 | For more information at the NIH Clinical Center contact National Cancer Institute Referral Office 888-624-1937 |
Find similar trials in Bethesda, MD
Related Studies
- Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 MutationPHASE1 · Recruiting · Institut de Recherches Internationales Servier · Birmingham, Alabama
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruiting · Massive Bio, Inc. · Birmingham, Alabama
- A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)PHASE2 · Enrolling By Invitation · Taiho Oncology, Inc. · Fountain Valley, California
- Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic SyndromePHASE1 · Recruiting · Syntrix Biosystems, Inc. · Jacksonville, Florida